Marker Therapeutics, Inc. (MRKR)
1.34
+0.02
(+1.52%)
USD |
NASDAQ |
Mar 20, 16:00
1.33
-0.01
(-0.75%)
After-Hours: 20:00
Marker Therapeutics Shareholders Equity (Quarterly) : 16.80M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | 722.17M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Kiniksa Pharmaceuticals International Plc | 567.61M |
| electroCore, Inc. | -1.709M |
| Agenus, Inc. | -271.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.07M |
| Total Liabilities (Quarterly) | 2.274M |
| Current Ratio | 8.386 |